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SIVmac1A11 and SIVmac239 are nonpathogenic and pathogenic molecular clones in rhesus macaques, respectively.
Although these viruses exhibit ;98% nucleotide and amino acid sequence homology, differences are found in the length of
the translation frames for several genes. SIVmac239 has a premature stop codon in nef, whereas SIVmac1A11 has a
premature stop codon in vpr and two premature stop codons in the intracytoplasmic domain of the env-transmembrane (TM)
subunit. Recombinant viruses, constructed through reciprocal exchange of large DNA restriction enzyme fragments between
SIVmac1A11 and SIVmac239, were evaluated in adult rhesus macaques. This in vivo analysis revealed that two or more
regions of the SIVmac genome were essential for high virus load and disease progression (Marthas et al., 1993. J. Virol. 67,
6047–6055). An important gap in knowledge remaining from this study was whether the premature stop codons in env-TM
of recombinant virus SIV1A11/239gag-env/1A11 (full-length vpr and nef, two stop codons in env-TM) reverted to coding
triplets in vivo. Here, we report that viral sequences in macaques, which succumbed to an AIDS-like disease after infection
with SIV1A11/239gag-env/1A11, exhibited reversion of both env-TM stop codons. In addition, antibodies to the intracyto-
plasmic domain of env-TM were detected in macaques containing revertant virus and showing disease; this finding indicates
that this domain of the env glycoprotein was expressed in vivo. Thus selection for viral variants with full-length env-TM
demonstrated that the cytoplasmic domain of the SIVmac env glycoprotein plays a role in viral persistence and immunode-
ficiency in primates. © 1998 Academic Press
Infection of macaques with variants and molecular
clones of simian immunodeficiency virus (SIV) provides
opportunities for defining viral determinants of persis-
tence and AIDS pathogenesis (reviewed in 8).
SIVmac1A11 establishes a low-level infection without
immunodeficiency disease in rhesus macaques (23),
whereas SIVmac239 produces a fatal AIDS-like disease
in this species (14). These two viruses exhibit ;98%
nucleotide and amino acid sequence homology; how-
ever, differences were found in the length of the trans-
lation frames for several genes (22). SIVmac239 has a
premature stop codon in nef, whereas SIVmac1A11 has
a premature stop codon in vpr and two premature stop
codons in the intracytoplasmic domain of the env-trans-
membrane (TM) subunit. The vpr gene is dispensable for
pathogenesis in SIVmac, presumably because this virus
contains the related vpx gene, which may possess some
functions redundant with vpr (7, 9, 19). Both SIVmac1A11
and SIVmac239 encode a full-length vpx gene (22). The
nef gene is important for maintaining high virus loads
and development of fatal immunodeficiency in adult ma-
caques; the premature stop codon in SIVmac239 nef
reverts in vivo to produce a full translation frame (15).
This latter study highlighted the powerful value of scor-
ing for reversions as a means for implicating the impor-
tance of a viral gene or genes for pathogenesis. Although
a clone of SIVmac239 with a large deletion in nef was not
pathogenic in adult macaques, virus with a deletion in
this gene produced a fatal AIDS-like disease in newborn
macaques (1). In striking contrast, SIVmac1A11 encodes
a full translation frame for nef yet is fully attenuated in
adult, juvenile, newborn, and fetal macaques (23–26, 40).
These in vivo findings, taken together with knowledge of
the sequence of the SIVmac1A11 genome, implicate a
gene or genes, in addition to the accessory genes vpr,
vpx, and nef, as a locus for attenuation in the SIVmac
system.
This report focused on the significance of the intracy-
toplasmic env-TM domain of SIVmac1A11 for viral load,
persistence, and pathogenesis. A precise origin or ori-
gins for the premature stop codons in SIVmac1A11
env-TM are not known. The first stop codon is in the
middle of env-TM (at position 733) at the splice acceptor
1 To whom reprint requests should be addressed at 3444 Tupper
Hall. Fax: (530) 752-4548.
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site for tat and rev (Fig. 1); this stop codon also has been
observed in several SIV and HIV-2 isolates and appears
to be generated by passage of these viruses, with full-
length env-TM, through certain human T-lymphoid tumor
cell lines (reviewed in 33). Interestingly, before molecular
cloning, SIVmac1A11 was propagated in the human T
cell tumor line (HUT-78) (23). Previous investigations
have suggested that there is selective pressure for a
full-length env-TM subunit in SIV-infected macaques (10,
16); however, these reports did not directly examine
env-TM changes in vivo and thus did not assess the
significance of the intracytoplasmic env domain for sim-
ian AIDS.
To elucidate viral determinants of pathogenesis, we
constructed replication-competent recombinant viruses
between SIVmac1A11 and SIVmac239 (2). Evaluation of
these recombinant viruses in rhesus macaques demon-
strated that two or more viral genes controlled viral load,
persistence, and disease potential (24, 32). These stud-
ies also indicated that the env-surface (SU) subunit
(gp130) was not the main determinant of pathogenesis of
SIVmac in vivo. Whether premature stop codons in the
genes of the recombinant viruses had reverted in vivo
was not determined. Accordingly, the current report fo-
cused on genetic changes in the env-TM translation
frame in rhesus macaques inoculated with a recombi-
nant virus containing a large internal region from SIV-
mac239 and the remainder from SIVmac1A11 (Fig. 1A).
This recombinant, designated SIVmac1A11/239gag-env/
1A11, contains full translation frames for vpr and nef but
two premature stop codons in the cytoplasmic portion of
env-TM (Fig. 1B) (2, 24). The premature stop codons in
env-TM are designated stop 1 (amino acid position 733)
and stop 2 (amino acid position 852).
Four juvenile macaques were inoculated by the intra-
venous route with cell-free preparations of both parental
viruses as well as SIVmac1A11/239gag-env/1A11. Table
1 shows the pattern of viral persistence as determined
by isolation of virus by coculturing macaque peripheral
blood mononuclear cells (PBMC) with the hybrid T/B cell
line CEMX174. Two macaques (Mmu23489 and
Mmu24942) infected with the recombinant virus exhib-
ited a transient viremia with respect to virus in PBMC.
Virus was consistently recovered from these two animals
only during the first 12 weeks of infection, although viral
nucleic acid could sometimes be amplified from their
PBMC or lymph nodes at later time points (24). No
clinical signs of disease were noted in either of these
FIG. 1. Genome structure of recombinant SIVmac1A11/239gag-env/1A11. (A) The construction of this and other recombinant viruses has been
described in detail (2). In brief, the region between a BamHI site in gag and a ClaI site at the env-SU/TM junction was exchanged between molecular
clones of SIVmac1A11 (GenBank No. M76764) and SIVmac239 (GenBank No. M33262). The region encompassed by the dotted line is composed of
SIVmac239 sequences. Detailed comparisons of SIVmac1A11 and SIVmac239 sequences are found in a previous report (22). (B) The black line
encompasses the env-TM subunit (gp41). Numbers indicate amino acid positions in the env glycoprotein; thus env-TM extends from amino acid 526
to amino acid 879. These positions are based on the sequence of SIVmac239. F designates the hydrophobic fusion peptide at the N-terminus of gp41,
and MS designates the hydrophobic membrane spanning domain of gp41. The amphipathic a-helices in gp41 are shown as lentivirus lytic peptides-1
and -2 (LLP-1 and LLP-2) (29, 38, 42). Locations of the two premature stop codons in env-TM of SIVmac1A11 are shown. In SIVmac1A11 env, changes
in the stop codon at position 852 also affect nef because the translation frames for the C-terminus of env and the N-terminus of nef overlap for 56
codons (Figs. 1B and 2) (41).
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two animals during the 4-year observation period or at
necropsy. SIVmac1A11 showed a similar pattern of tran-
sient cell-associated viremia and lack of pathogenicity
(Table 1) (24). In contrast, two other macaques
(Mmu24268 and Mmu24728) inoculated with
SIVmac1A11/239gag-env/1A11 displayed a pattern of
persistent cell-associated viremia throughout the entire
infection period. Viral persistence in PBMC was also a
feature of infection with the pathogenic molecular clone
SIVmac239 (Table 1) (24). These two animals, Mmu24268
and Mmu24728, exhibited persistent generalized lymph-
adenopathy, splenomegaly, and wasting during the latter
stages of infection. Salient features at necropsy at 83
weeks postinfection (p.i.) for Mmu24268 were severe
weight loss, thrombocytopenia and lymphopenia, thymic
atrophy, and enterocolitis due to Mycobacterium avium.
The necropsy for Mmu24728 at 201 weeks p.i. revealed
widespread lymphoid hyperplasia and extensive serosi-
tis in many peritoneal organs. In this animal, gastroin-
testinal contents were found within the peritoneum, in-
dicating a perforation. The opportunistic pathogen cyto-
megalovirus (CMV) was suspected; intestinal perforation
due to CMV infection has been reported in patients with
AIDS (17, 27).
We examined sequences of the env-TM subunit of
viruses recovered from macaques infected with
SIVmac1A11/239gag-env/1A11 to test the hypothesis that
a full-length translation frame for this subunit of the env
glycoprotein was required for viral persistence and dis-
ease. Viral DNA sequences were amplified from ma-
caque cells at 12 and 49 weeks (Mmu24268 and
Mmu24728) or 12 and 62 weeks (Mmu24942 and
Mmu23489) after infection. Virus was also recovered
from Mmu24268 and Mmu24728, at or shortly before
necropsy. A 855 nucleotide fragment encompassing the
39 portion of the env gene and the 59 portion of the nef
gene was amplified by PCR, cloned into a plasmid vector,
and sequenced by the chain termination method with
dideoxynucleotide triphosphates and DNA polymerase.
For PCR amplification of viral DNA, nested primers to
conserved sequences in the env-TM domain of the
SIVmac1A11 env gene were used. Nucleotide (nt) posi-
tions are from the sequence of the SIVmac1A11 clone
(M76764). Oligonucleotide primers were designed by the
Geneworks Program from Intelligenetics (Mountainview,
CA). The outer pair is primer SIV340.20 (nt 8641–8660)
59-GGTTTGACCTTGCTTCTTGG-39 and primer SIV341.20
(nt 9661–9680) 39-GGTCGAGTTTGAAGGGTCAC-59. The
inner pair is primer SIV342.22 (nt 8737–8758) 59-
TGCTAGCTAAGTTAAGGCAGGG-39 and primer SIV343.19
(nt 9573–9591) 39-GGGTTTCTGTAAACCGACC-59. Tem-
plate DNA for amplification was prepared with either the
QIAmp Blood Kit (Qiagen, Chatsworth, CA) from ma-
caque PBMC or with the QIAmp Tissue Kit from lymph
TABLE 1
Virus Persistence in Macaques Inoculated with Molecular Clones of SIVmaca
Virus and
Macaque
Weeks postinfection
2 4 6 8 12 27 49 55 62 75 104 200
SIVmac1A11
Mmu24293 1b 1 2b 2 2 2 2 2 2 2 2 2
Mmu24943 1 1 1 2 2 2 2 2 2 2 2 2
Mmu24971 1 1 1 2 2 2 2 2 2 2 2 2
Mmu25000 1 1 2 2 2 2 2 2 2 2 2 2
SIVmac239
Mmu24783 1 1 1 1 1 1 1 1 1 1c
Mmu24848 1 1 1 1 1 1 1 1 1 1 1 NDd
Mmu24864 1 1 1 1 1 1 1 1 1 1c
Mmu24911 1 1 1 1 1 1c
SIVmac1A11/239gag-env/1A11 recombinant virus
Mmu24268 1 1 1 1 1 1 1 1 1 1c
Mmu24728 1 1 1 1 1 1 1 1 1 1 1 1c
Mmu23489 1 1 1 2 1 2 2 2 2 2 2 2
Mmu24942 1 1 1 1 2 2 2 2 1 2 2 2
a This table, partially excerpted from our previous publication (25), shows the results of virus isolation from 106 PBMC at several time points after
infection of juvenile rhesus macaques infected with SIVmac1A11, SIVmac239, and the SIVmac1A11/239 recombinant virus. Each Macaca mulatta
(Mmu) is identified with a five-digit number.
b The symbols 1 and 2 indicate that cultures of 106 PBMC from each animal were positive or negative for infectious virus, respectively, in the
coculture assay for virus isolation described in the text.
c Mmu24268 and Mmu24728 were euthanized because of signs of AIDS-like disease at 83 and 201 weeks after infection, respectively. Similarly,
animals infected with parental SIVmac239 were euthanized at the time points indicated.
d ND, not determined.
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node (Table 1). PCR was done with 0.4–3.5 mg of DNA
template in a final volume of 50 ml of the following
reaction mix: 10 mM Tris–HCl, pH 8.3; 50 mM KCl; 1.5 mM
MgCl2; 200 mM concentration each of dATP, dCTP, dGTP,
and dTTP; 40 pmol of each outer primer; and 1–2.5 units
of AmpliTaq DNA polymerase (Perkin-Elmer Cetus). This
reaction mix was transferred to a DNA thermal cycler for
one cycle at 94°C for 4 min, followed by 35 cycles at
94°C for 1 min (denaturation), 60°C for 1 min (primer
annealing), and 72°C for 1 min (extension). This first
round of PCR amplification was followed with a 7-min
incubation at 72°C. For the second round, 5–15 ml of the
first-round PCR mix was added to a final volume of a
reaction mix identical to the first-round mix; however, this
mix contained 40 pmol of each inner primer. Incubation
periods and temperatures for the second round of PCR
amplification were the same as for the first round as
described above. Appropriate assays were done to rule
out potential reagent contamination. The nested PCR
amplification method allows visual detection (ethidium
bromide staining after electrophoresis on agarose gels)
of 1040- and 855-nt DNA fragments after the first and
second rounds, respectively. PCR amplification of b-glo-
bin DNA sequences with primers complementary to the
first exon of the human b-globin gene (45) was also
performed on virus-negative samples to assess recovery
of cellular DNA and to monitor for inhibitors of Taq
polymerase in test DNA samples. The PCR amplification
product from rhesus PBMC was cloned directly into the
TA cloning vector pCRII or pCR2.1 according to condi-
tions provided by the supplier (InVitrogen, La Jolla, CA).
The PCR amplification product from lymph node was
purified by agarose gel electrophoresis and the QIAex
method (Qiagen) and then cloned into the pCRII vector.
Table 2 shows the results of sequence analysis of the
premature stop codons of multiple clones obtained from
each sampling of four macaques infected with the re-
combinant virus SIVmac1A11/239gag-env/1A11. Two ma-
caques in this group (Mum24728 and Mmu24268) exhib-
ited a pattern of persistent cell-associated virus through-
out the course of infection and progressed to SAIDS
(Table 1). Virus from Mmu24728 retained both premature
stop codons in env-TM at 12 and 49 weeks after infection
(Table 2). However, analysis of samples obtained from
this animal at 194 weeks revealed that both of these stop
codons had reverted. The precise time that reversions
began could not be established due to an absence of
appropriate samples from intermediate time points; how-
ever, this animal’s clinical history noted marked gener-
alized lymphadenopathy at 130 weeks p.i. The second
animal with persistent infection, Mmu24268, showed re-
version of one or both premature stop codons in env-TM
as early as 12 weeks after infection (Table 2). At 49 and
83 weeks after infection, all viral sequences obtained
from Mmu24268 encoded the full-length env-TM subunit.
Mmu24268 had higher loads of cell-associated virus in
PBMC and a more rapid course of disease progression
than Mmu24728 (Table 1); these observations were con-
sistent with the finding that at 12 weeks after infection,
virus from the former macaque contained reversions in
the env-TM premature stop codons, whereas virus from
the latter macaque retained both of these stop codons. In
the clones examined for this study, reversion of the first
stop codon (stop 1) invariably resulted in a glutamine
codon (CAG) in the env-TM reading frame; reversion of
the second stop codon (stop 2) resulted in a tryptophan
codon (TGG). These changes corresponded to the wild-
type SIVmac239 env-TM sequence. Because the C-ter-
TABLE 2
Changes in env-TM Stop Codons in Macaques Infected with the SIV1A11/239gag-env/1A11 Recombinant or SIVmac1A11
Recombinant SIV1A11/239gag-env/1A11 SIVmac1A11
Time post-
infection
Mmu24268 Mmu24728 Mmu24942 Mmu23489 Mmu24140
No. of
clones Stop 1 Stop 2
No. of
clones Stop 1 Stop 2
No. of
clones Stop 1 Stop 2
No. of
clones Stop 1 Stop 2
No. of
clones Stop 1 Stop 2
Input TAG TGA TAG TGA TAG TGA TAG TGA TAG TGA
Early 1 TAG TGA 11 TAG TGA 11 TAG TGA 6 TAG TGA NA
12 weeks 3 CAG TGA
4 CAG TGG
Late 8 CAG TGG 8 TAG TGA 8 TAG TGA 8 TAG TGA 10 TAG TGA
;1 yr 2 TAG TGG
2 CAG TGA
2 CAG TGG
;Nx 4 CAG TGG 8 CAG TGG NP NP NA
Note. CAG encodes glutamine (Gln); TGG encodes tryptophan (Trp). ;1 yr, samples were taken at 49 weeks for Mmu24268 and Mmu24728 and
at 62 weeks for Mmu24942 and Mmu23489. ;Nx, samples at 83 weeks (necropsy) for Mmu24268 and 194 weeks for Mmu24728, 24942, and 23489
(necropsy at 201 weeks for Mmu24728 and at 208 weeks for Mmu 24942 and 23489). NP, negative by PCR for detection and recovery of viral DNA
sequences at 194 weeks. NA, samples were not available at these time points.
12 RAPID COMMUNICATION
minus of env-TM and the N-terminus of Nef are derived
from overlapping translation frames (Fig. 1B), reversion
of stop 2 in env-TM also changes a glutamate codon to
a glycine codon at amino acid position 29 in the nef
translation frame (41). Nef of SIVmac1A11 downregulates
CD4 and associates with a cellular serine kinase in
infected cells (35) (I. Khan, E. Sawai, and current authors,
unpublished results); thus this allele of nef appears to be
functional.
In the remaining two macaques (Mmu23489 and
Mmu24942) showing transient or very low virus loads
after infection with SIVmac1A11/239gag/env/1A11 (Table
1), all env-TM clones recovered at 12 weeks p.i. retained
both premature stop codons (Table 2). Viral clones rep-
resenting the env-TM region were obtained at 62 weeks
p.i. by amplification of DNA from either macaque PBMC
cocultured with CEMX174 cells (Mmu23489) or lymph
node tissue (Mmu24942). Analysis of these clones re-
vealed that both premature stop codons remained un-
changed in Mmu23489 (Table 2). A complex pattern of
stop codons and reversions was observed in env-TM
sequences obtained from Mmu24942; however, a major-
ity (8 of 14) of clones retained both stop codons, and four
additional clones retained at least one stop codon (Table
2). Although Mmu23489 and Mmu24942 remained
healthy with no clinical signs of immunodeficiency and
undetectable virus in PBMC, both animals were eutha-
nized at 208 weeks p.i., and necropsies were performed.
Histopathological analysis of lymphoid and other organs
also did not reveal any disease signs. Several attempts
to detect and recover viral DNA sequences by PCR
amplification of DNA from PBMC collected at 194 weeks
p.i. from these two animals were unsuccessful (Table 2).
The analysis of revertant viruses was extended to a
control juvenile macaque (Mmu24140) infected with the
highly attenuated molecular clone SIVmac1A11. Analysis
of viral DNA amplified by PCR from PBMC samples at 83
weeks p.i. showed that both premature stop codons in
env-TM remained unchanged in this animal (Table 2).
Because virus load was extremely low in macaques
infected with SIVmac1A11 at 12 weeks p.i. and thereafter
(Table 1), it was not possible to obtain viral DNA samples
from the chronic phase of infection in additional ma-
caques inoculated with this highly attenuated virus.
To determine whether the intracytoplasmic domain of
the env-TM subunit, after the first premature stop codon
(amino acid position 733; Fig. 1B), was expressed in
infected macaques, sera from these animals were tested
for antibodies to a recombinant viral polypeptide, which
represented sequences from the C-terminal portion of
env-TM. This polypeptide was produced in insect cells
harboring a baculovirus expression vector that directed
expression of env-TM sequences between codons 735–
880 of SIVmac239 (unpublished results). Sera obtained at
yearly intervals from all four macaques, as well as from
control macaques infected with either SIVmac239 or
SIVmac1A11, were tested for reactivity to this env-TM
antigen by immunoblot at 1:100 dilution of each serum
sample. In addition, the titers of antiviral antibodies in
these sera were measured in a whole-virus ELISA assay.
Results of both of these immunological methods are
shown in Table 3. Immunoblot analysis of sera from the
macaques displaying persistent infection and disease
(Mmu24268 and Mmu24728) revealed that both animals
expressed antibodies to the C-terminal portion of env-
TM. Furthermore, the appearance of antibody reactivity
to env-TM was consistent with the time frame observed
for reversion of env-TM stop codons at the viral DNA
level: Mmu24268, whose lymphocytes harbored ’’open-
TM’’ virus as early as 12 weeks p.i., showed reactivity
with the C-terminal env-TM polypeptide at 1 year p.i.
Mmu24728, in which neither stop codon had reverted by
49 weeks p.i., did not show antibody reactivity against
C-terminal env-TM sequences until 3 years p.i. Both
macaques with transient infection (Mmu23489 and
Mmu24942) did not demonstrate detectable levels of
antibodies directed toward the env-TM polypeptide, al-
though these animals’ sera exhibited high-titer reactivity
against SIV antigens in a whole-virus ELISA (Table 3).
Sera from control animals infected up to 4 years with
TABLE 3
Serum Antibodies Directed against Whole SIV and the C-Terminal Region of env-TM in Macaques Infected
with Recombinant SIV1A11/239gag-env/1A11
Years post-
infection
Mmu24268 Mmu24728 Mmu24942 Mmu23489
Whole SIV TM C-terminal Whole SIV TM C-terminal Whole SIV TM C-terminal Whole SIV TM C-terminal
1 1:1,638,400 POS 1:409,600 neg 1:51,200 neg 1:51,200 neg
1.5a 1:409,600 POS
2 1:409,600 neg 1:51,200 neg 1:12,800 neg
3 1:409,600 POS 1:25,600 neg 1:12,800 neg
4 1:409,600 POS 1:25,600 neg 1:3,200 neg
Note. POS, positive by immunoblot reactivity with 1:100 dilution of serum. neg, negative by immunoblot reactivity with 1:100 dilution of serum.
a Mmu24268 was euthanized at ;1.5 years postinfection.
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SIVmac1A11 did not recognize the env-TM polypeptide,
although sera from a macaque infected with SIVmac239
(Mmu24783) did recognize this antigen (data not shown).
Taken together, these results provided evidence that
reversion of premature stop codons in env-TM was as-
sociated with expression in vivo of immunoreactive viral
protein from the intracytoplasmic domain of the env gly-
coprotein.
The major finding in this report is that the population of
viral variants changes during infection with the
SIVmac1A11/239gag-env/1A11 recombinant, from a vari-
ant with two stop codons in env-TM to variants with
full-length env-TM. Additionally, restoration of full-length
env-TM correlated with viral persistence and disease
progression, and therefore supported the hypothesis that
this portion of the env glycoprotein has a function or
functions critical for pathogenesis. Evidence from this
study suggests that although reversion of the env-TM
stop codons contributed significantly to the persistence
and pathogenicity of the recombinant virus, other factors
(possibly including sequence modifications at other ge-
netic loci in the virus) also may have been involved.
Rhesus macaque 24728 remained infected throughout
the study but did not develop disease until ;3.5 years
p.i., coincident with reversion of the two premature stop
codons in env-TM. This result supported a correlation
between reversion of the stop codons and development
of disease; nevertheless, it also implied that SIV was
capable of persisting at low but detectable levels in
macaques in the absence of a full-length env-TM reading
frame. Conversely, in one macaque that did not develop
disease, Mmu24942, a minority of clones analyzed at 62
weeks p.i. showed reversion of either the first, the sec-
ond, or both stop codons. Nevertheless, Mmu24942
failed to show serum immunoreactivity to a env-TM
polypeptide at up to 4 years p.i., suggesting that the
full-length env-TM was not expressed to high levels in
this animal. Therefore, in this animal, partial reversion of
the env-TM stop codons (in a minority of viral sequences)
did not correlate with high virus load or progression to
disease in the 4-year observation period. Because
Mmu24942 was euthanized at the conclusion of the
study, no additional long-term clinical information can be
obtained. During the time that the work in our report was
in progress, in vivo studies were described for a clone of
SIV-BK28, which contains one premature stop codon
(corresponding to the first stop codon at position 733 in
the SIVmac239 sequence); reversion to a full env-TM in
macaques infected with this viral clone was also asso-
ciated with development of simian AIDS (6).
Analysis of structural and biochemical features of viri-
ons and genetic studies of viral mutants in tissue culture
cells have implicated several functions for the intracyto-
plasmic domain of env-TM (11). In vitro properties of
lentiviruses influenced by env-TM include stability and
level of incoproration of env glycoprotein into virions, cell
tropism, cell–cell fusion, cytopathicity (4, 13, 18, 31, 34, 36,
37, 46), polarized release of virions (3, 20, 21), and inter-
action with the cellular protein calmodulin (12, 28–30, 38,
39, 44). To determine the significance of these various in
vitro functions, it will be necessary to closely couple
biochemical analyses with additional animal inoculation
studies on deletion and site-specific point mutations in
SIVmac env-TM. Such studies will also contribute to
efforts aimed at designing and enhancing the efficacy of
live-attenuated viral vaccines (5, 25). The relative contri-
bution of truncations in both vpr and env-TM to attenua-
tion of SIVmac1A11 remain to be assessed. Nonetheless,
because SIVmac239 clones with multiple deletions in
accessory genes are pathogenic in newborn macaques
(1, 43) and because of the lack of pathogenicity of the
closely related SIVmac1A11 (23–26, 40), the intracyto-
plasmic domain of env-TM is an attractive locus for
constructing novel live-attenuated viral vaccines for eval-
uation in nonhuman primate models for lentivirus infec-
tion and AIDS.
ACKNOWLEDGMENTS
We thank Ms. Teresa Low, Heather Kerr, and Mr. Sanjay Rajpara for
expert technical assistance in various aspects of this project. Drs. Dan
Canfield and Chris Miller are gratefully acknowledged for performing
the pathology studies. We also thank Drs. Murray Gardner, Pierre
Sonigo, Ron Montelaro, and Michael Endres for helpful and provocative
discussions. This research was supported in part by grants from the
National Institutes of Health: RO1-AI39415 to Murray Gardner and
RR-00169 the Base Grant to the California Regional Primate Research
Center. B.L.S. was a postdoctoral fellow of SIDAction, Paris, France,
and received a Pediatric AIDS Foundation Short-Term Travel Award.
M.L.M. is an Elizabeth Glaser Scientist supported in part by the Eliza-
beth Glaser Pediatric AIDS Foundation.
REFERENCES
1. Baba, T. W., Jeong, Y. S., Pennick, D., Bronson, R., Greene, M. F., and
Ruprecht, R. M. (1995). Pathogenicity of live attenuated SIV after
mucosal infection of neonatal macaques. Science 267, 1820–
1825.
2. Banapour, B., Marthas, M. L., Ramos, R. A., Lohman, L., Unger, R. E.,
Gardner, M. B., Pedersen, N. C., and Luciw, P. A. (1991). Identi-
fication of viral determinants of macrophage tropism for simian
immunodeficiency virus SIVmac. J. Virol. 65, 5798–5805.
3. Boge, M., Wyss, S., Bonifacino, J. S., and Thali, M. (1997). A mem-
brane-proximal tyrosine-based signal mediates internalization
of the HIV-1 envelope glycoprotein via interaction with the AP-2
clatharin adaptor. J. Biol. Chem. 273, 15773–15778.
4. Chakrabarti, L., Emerman, M., Tiollais, P., and Sonigo, P. (1989).
The cytoplasmic domain of simian immunodeficiency virus
transmembrane protein modulates infectivity. J. Virol. 63,
4395–4403.
5. Daniel, M. D., Kirchhoff, F., Czajak, S. C., Sehgal, P. K., and
Desrosiers, R. C. (1992). Protective effects of a live attenuated
SIV vaccine with a deletion in the nef gene. Science 258,
1938–1941.
6. Edmondson, P., Murphy-Corb, M., Martin, L. N., Delahunty, C.,
Heeney, J., Kornfeld, H., Donahue, P. R., Learn, G. H., Hood, L.
and Mullins, J. I. (1998). Evolution of a simian immunodeficiency
virus pathogen. J. Virol. 72, 405–414.
14 RAPID COMMUNICATION
7. Fletcher, T. M., Brichacek, B., Sharova, N., Newman, M. A., Stivahtis,
G., Sharp, P. M., Emerman, M., Hahn, B. H., and Stevenson, M.
(1996). Nuclear import and cell cycle arrest functions of the
HIV-1 Vpr protein are encoded by two separate genes in HIV-2/
SIV(SM). EMBO J. 15, 6155–6165.
8. Gardner, M. B., and Luciw, P. A. (1997). Simian retroviruses. In “AIDS
and Other Manifestations of HIV Infection.” (G. Wormser, Ed.), pp
217–256. Raven Press, New York,
9. Gibbs, J. S., Lackner, A. A., Lang, S. M., Simon, M. A., Sehgal,
P. K., Daniel, M. D., and Desrosiers, R. C. (1995). Progression
to AIDS in the absence of a gene for vpr or vpx. J. Virol. 69,
2378–2383.
10. Hirsch, V. M., and Johnson, P. R. (1989). SIV adaptation to human
cells [correspondence]. Nature 341, 573–574.
11. Hunter, E. (1994). Macromolecular interactions in the assembly of
HIV and other retroviruses. Sem. Virol. 5, 71–83.
12. Ishikawa, H., Sasaki, M., Noda, A., and Koga, Y. (1998). Apoptosis
induction by the binding of the carboxyl terminus of human
immunodeficiency virus type 1 gp160 to calmodulin. J. virol. 72,
6574–6580.
13. Johnston, P. B., Dubay, J. W., and Hunter, E. (1993). Truncations of
the simian immunodeficiency virus transmembrane protein con-
fer expanded virus host range by removing a block to virus entry
into cells. J. Virol. 67, 3077–3086.
14. Kestler, H., Kodama, T., Ringler, D., Marthas, M., Pedersen, N.,
Lackner, A., Regier, D., Sehgal, P., Daniel, M., and King, N. (1990).
Induction of AIDS in rhesus monkeys by molecularly cloned
simian immunodeficiency virus [see comments]. Science 248,
1109–1112.
15. Kestler, H. W., Ringler, D. J., Mori, K., Panicali, D. L., Sehgal, P. K.,
Daniel, M. D., and Desrosiers, R. C. (1991). Importance of the nef
gene for maintenance of high virus loads and for the develop-
ment of AIDS. Cell 65, 651–662.
16. Kodama, T., Wooley, D. P., Naidu, Y. M., Kestler, H. W., Daniel, M. D.,
Li, Y., and Desrosiers, R. C. (1989). Significance of premature
stop codons in env of simian immunodeficiency virus. J. Virol.
63, 4709–4714.
17. Kram, H. B., and Shoemaker, W. C. (1990). Intestinal performation
due to cytomegalovirus infection in patients with AIDS. Dis. Col.
Rectum 33, 1037–1040.
18. LaBranche, C. C., Sauter, M. M., Haggarty, B. S., Vance, P. J.,
Romano, J., Hart, T. K., Bugelski, P. J., Marsh, M. and Hoxie, J. A.
(1995). A single amino acid change in the cytoplasmic domain of
the simian immunodeficiency virus transmembrane molecule
increases envelope glycoprotein expression on infected cells.
J. Virol. 69, 5217–5227.
19. Lang, S., Weeger, M., Stahl-Hennig, C., Coulibaly, C., Hunsmann, G.,
Muller, J., Muller-Hermelink, H., Fuchs, D., Wachter, H., Daniel,
M. M., Desrosiers, R. C., and Fleckenstein, B. (1993). Importance
of vpr for infection of rhesus monkeys with simian immunode-
ficiency virus. J. Virol. 67, 902–912.
20. Lodge, R., Gottlinger, H., Gabuzda, D., Cohen, E. A., and Lemay, G.
(1994). The intracytoplasmic domain of gp41 mediates polarized
budding of human immunodeficiency virus type I in MDCK cells.
J. Virol. 68, 4857–4861.
21. Lodge, R., Lalonde, J.-P., Lamay, G., and Cohen, E. A. (1997). The
membrane-proximal intracytoplasmic tyrosine residue of HIV-1
envelope glycoprotein is critical for basolateral targeting of viral
budding in MDCK cells. EMBO J. 16, 695–705.
22. Luciw, P. A., Shaw, K. E. S., Unger, R. E., Planelles, V., Stout, M. W.,
Lackner, J. E., Pratt-Lowe, E., Leung, N. J. Banapour, B. and
Marthas, M. L. (1992). Genetic and biological comparisons of
pathogenic and nonpathogenic molecular clones of simian im-
munodeficiency virus (SIVmac). AIDS Res. Hum. Retroviruses 8,
395–402.
23. Marthas, M. L., Banapour, B., Sutjipto, S., Siegel, M. E., Marx, P. A.,
Gardner, M. B., Pedersen, N. C., and Luciw, P. A. (1989). Rhesus
macaques inoculated with molecularly cloned simian immuno-
deficiency virus. J. Med. Primatol. 18, 311–319.
24. Marthas, M. L., Ramos, R. A., Lohman, B. L., Van Rompay, K., Unger,
R. E., Miller, C. J., Banapour, B., Pedersen, N. C., and Luciw, P. A.
(1993). Viral determinants of simian immunodeficiency virus
(SIV) virulence in rhesus macaques assessed by using attenu-
ated and pathogenic molecular clones of SIVmac. J. Virol. 67,
6047–6055.
25. Marthas, M. L., Sutjipto, S., Higgins, J., Lohman, B., Torten, J., Luciw,
P. A., Marx, P. A., and Pedersen, N. C. (1990). Immunization with
a live, attenuated simian immunodeficiency virus (SIV) prevents
early disease but not infection in rhesus macaques challenged
with pathogenic SIV. J. Virol. 64, 3694–3700.
26. Marthas, M. L., Van Rompay, K. K. A., Otsyula, M., Miller, C. J.,
Canfield, D. R., Pedersen, N. C., and McChesney, M. B. (1995).
Viral factors determine progression to AIDS in SIV-infected new-
born macaques. J. Virol. 69, 4198–4205.
27. Meza, A. D., Bin-Sagheer, S., Zuckerman, M. J., Morales, C. A., and
Verghese, A. (1994). Ileal perforation due to cytomegalovirus
infection. J. Nat. Med. Assoc. 86, 145–148.
28. Miller, M. A., Cloyd, M. W., Liebmann, J., Rinaldo, C. R., Islam, K. R.,
Wang, S. Z. S., Mietzner, T. A., and Montelaro, R. C. (1993a).
Alterations in cell membrane permeability by the lentivirus lytic
peptide (LLP-1) of HIV-1 transmembrane protein. Virology 196,
89–100.
29. Miller, M. A., Garry, R. F., Jaynes, J. M., and Montelaro, R. C. (1991).
A structural correlation between lentivirus transmembrane pro-
teins and natural cytolytic peptides. AIDS Res. Human Retrovi-
ruses 7, 511–519.
30. Miller, M. A., Mietzner, T. A., Cloyd, M. W., Robey, W. G., and
Montelaro, R. C. (1993b). Identification of calmodulin-binding
and inhibitory peptide domain in the HIV-1 transmembrane gly-
coprotein. AIDS Res. Hum. Retroviruses 9, 1057–1065.
31. Mulligan, M. J., Yamshchikov, G. V. Ritter, G. S., Gao, F., Jin, M. J.,
Nail, C. D., Spies, C. P., Hahn, B. H., and Compans, R. W. (1992).
Cytoplasmic domain truncation enhances fusion activity by the
exterior glycoprotein complex of human immunodeficiency virus
type 2 in selected cell types. J. Virol. 66, 3971–3975.
32. Novembre, F., Johnson, P., Lewis, M., Anderson, D., Klumpp, S.,
McClure, H., and Hirsch, V. (1993). Multiple determinants con-
tribute to pathogenicity of the acutely lethal simian immunode-
ficiency virus SIVsmmPBj variant. J. Virol. 67, 2466–2474.
33. Pancino, G., Ellerbock, H., Sitbon, M., and Sonigo, P. (1994). Con-
served framework of envelope glycoproteins among lentivi-
ruses. Curr. Topics Micro. Immunol. 188, 77–105.
34. Ritter, G. D., Mulligan, M. J., Lydy, S. L., and Compans, R. W. (1993).
Cell fusion activity of the simian immunodeficiency virus enve-
lope protein is modulated by the intracytoplasmic domain. Vi-
rology 197, 255–264.
35. Sawai, E. T., Baur, A. S., Peterlin, B. M., Levy, J. A., and Cheng-
Mayer, C. (1995). A conserved domain and membrane targeting
of Nef from HIV and SIV are required for association with a
cellular serine kinase. J. Biol. Chem. 270, 15307–15314.
36. Shacklett, B. L., Denesvre, C., Boson, B., and Sonigo, P. (1998).
Features of the SIVmac transmembrane glycoprotein that are
important for Env functions. AIDS Res. Hum. Retroviruses 14,
373–383.
37. Spies, C. P., Ritter, G. D., Mulligan, M. J., and Compans, R. W. (1994).
Truncation of the cytoplasmic domain of the simian immunode-
ficiency virus envelope glycoprotein alters the conformation of
the external domain. J. Virol. 68, 585–591.
38. Srinivas, S. K., Srinivas, R. V., Anantharamaiah, G. M., Compans,
R. W., and Segrest, J. P. (1993). Cytosolic domain of the HIV
envelope glycoproteins binds to CaM and inhibits CaM-regu-
lated proteins. J. Biol. Chem. 268, 22895–22899.
39. Srinivas, S. K., Srinivas, R. V., Anantharamaiah, G. M., and Segrest,
J. P. (1992). Membrane interactions of synthetic peptides corre-
15RAPID COMMUNICATION
sponding to amphipathic helical segments of the human immu-
nodeficiency virus type-1 envelope glycoprotein. J. Biol. Chem.
267, 7121–7127.
40. Tarantal, A. F., Marthas, M. L., Gargosky, S. E., Otysula, M., Mc-
Chesney, M. B., Miller, C. J., and Hendrickx, A. G. (1995). Effects
of viral virulence on intrauterine growth in SIV-infected fetal
rhesus macaques (Macaca mulatta). J. AIDS 10, 129–138.
41. Unger, R. E., Marthas, M. L. Pratt, L. E., Padrid, P. A., and Luciw, P. A.
(1992). The nef gene of simian immunodeficiency virus
SIVmac1A11. J. Virol. 66, 5432–5442.
42. Venable, R. M., Pastor, R. W., Brooks, B. R., and Carson, F. W. (1989).
Theoretically determined three-dimensional structures for am-
phipathic segments of HIV-1 gp41 envelope protein. AIDS Res.
Hum. Retroviruses 5, 7–22.
43. Wyand, M. S., Manson, K. H. Lackner, A. A., and Desrosiers, R. C.
(1997). Resistance of neonatal monkeys to live attenuated vaccine
strains of simian immunodeficiency virus. Nat. Med. 3, 32–36.
44. Yuan, T., Mietzner, T. A., Montelaro, R. C., and Vogel, H. J. (1995).
Characterization of the calmodulin binding domain of SIV trans-
membrane glycoprotein by NMR and CD spectroscopy. Bio-
chemistry 34, 10690–10696.
45. Zack, J. A., and Arrigo, S. J. (1990). HIV-1 entry into primary lympho-
cytes: Molecular analysis reveals a labile, latent viral structure.
Cell 61, 213–222.
46. Zingler, K., and Littman, D. R. (1993). Truncation of the cytoplasmic
domain of the simian immunodeficiency virus envelope glyco-
protein increases env incorporation into particles and fusoge-
nicity and infectivity. J. Virol. 67, 2824–2831.
16 RAPID COMMUNICATION
